Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Desrayaud

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 26, 2009
Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activityCarsten Spanka, Ralf Glatthar, Sandrine Desrayaud, et al.
Journal of Chemical Information and Modeling|June 23, 2022
Predicting In Vivo Compound Brain Penetration Using Multi-task Graph Neural NetworksSeid Hamzic, Richard Lewis, Sandrine Desrayaud, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 17, 2004
6-[2-(adamantylidene)-hydroxybenzoxazole]-O-sulfamate, a steroid sulfatase inhibitor for the treatment of androgen- and estrogen-dependent diseasesAndreas Billich, Josef G Meingassner, Peter Nussbaumer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 15, 2024
Improving In Vitro-In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound MoleculesMarkus Trunzer, Joana Teigão, Felix Huth, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2011
Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitorsHeinrich Rueeger, Jean-Michel Rondeau, Clive McCarthy, et al.
Neuropharmacology|August 14, 2012
MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlatesNicolas Morin, Laurent Grégoire, Marc Morissette, et al.
Bioorganic & Medicinal Chemistry Letters|September 12, 2012
Discovery of 1H-pyrrolo[2,3-c]pyridine-7-carboxamides as novel, allosteric mGluR5 antagonistsManuel Koller, David A Carcache, David Orain, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2013
Discovery of novel indolinone-based, potent, selective and brain penetrant inhibitors of LRRK2Thomas Troxler, Paulette Greenidge, Kaspar Zimmermann, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 15, 2012
Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's diseaseJill Bouchard, Jennifer Truong, Kristofer Bouchard, et al.
Chemmedchem|May 8, 2016
Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral ExposureMarianne Fouché, Michael Schäfer, Jörg Berghausen, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|November 26, 2009
Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activityCarsten Spanka, Ralf Glatthar, Sandrine Desrayaud, et al.
Journal of Chemical Information and Modeling|June 23, 2022
Predicting In Vivo Compound Brain Penetration Using Multi-task Graph Neural NetworksSeid Hamzic, Richard Lewis, Sandrine Desrayaud, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 17, 2004
6-[2-(adamantylidene)-hydroxybenzoxazole]-O-sulfamate, a steroid sulfatase inhibitor for the treatment of androgen- and estrogen-dependent diseasesAndreas Billich, Josef G Meingassner, Peter Nussbaumer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 15, 2024
Improving In Vitro-In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound MoleculesMarkus Trunzer, Joana Teigão, Felix Huth, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2011
Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitorsHeinrich Rueeger, Jean-Michel Rondeau, Clive McCarthy, et al.
Neuropharmacology|August 14, 2012
MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlatesNicolas Morin, Laurent Grégoire, Marc Morissette, et al.
Bioorganic & Medicinal Chemistry Letters|September 12, 2012
Discovery of 1H-pyrrolo[2,3-c]pyridine-7-carboxamides as novel, allosteric mGluR5 antagonistsManuel Koller, David A Carcache, David Orain, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2013
Discovery of novel indolinone-based, potent, selective and brain penetrant inhibitors of LRRK2Thomas Troxler, Paulette Greenidge, Kaspar Zimmermann, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 15, 2012
Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's diseaseJill Bouchard, Jennifer Truong, Kristofer Bouchard, et al.
Chemmedchem|May 8, 2016
Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral ExposureMarianne Fouché, Michael Schäfer, Jörg Berghausen, et al.
Pageof 4